Legal & General Group
PYXS icon

Legal & General Group’s Pyxis Oncology PYXS Stock Holding History

Legal & General Group’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,219
Closed -$4.13K – 3511
2025
Q1 		$4.13K Hold
4,219
– – ﹤0.01% 3305
2024
Q4 		$6.58K Hold
4,219
– – ﹤0.01% 3308
2024
Q3 		$15.5K Hold
4,219
– – ﹤0.01% 3148
2024
Q2 		$13.9K Buy
+4,219
New +$17.7K ﹤0.01% 3178
2022
Q3 		– Sell
-833
Closed -$2K – 3480
2022
Q2 		$2K Sell
833
-142
-15% -$378 ﹤0.01% 3489
2022
Q1 		$4K Hold
975
– – ﹤0.01% 3520
2021
Q4 		$11K Buy
+975
New +$11.2K ﹤0.01% 3443

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's PYXS Position: Q2 2025 in Review

Legal & General Group sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 4,219 shares — an estimated $4.13K sold.

Legal & General Group first reported a position in PYXS in Q4 2021 and held it in 7 quarters. The position peaked at $15.5K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • Legal & General Group reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 4,219 Pyxis Oncology shares in Q2 2025, an estimated $4.13K.
  • Legal & General Group first reported a position in Pyxis Oncology in Q4 2021 and held it in 7 quarters.
  • Legal & General Group's Pyxis Oncology position peaked at $15.5K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.